PspA Family Distribution, Antimicrobial Resistance and Serotype of Streptococcus pneumoniae Isolated from Upper Respiratory Tract Infections in Japan

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Hotomi, Muneki ^a   Togawa, Akihisa ^a   Kono, Masamitsu ^a   Ikeda, Yorihiko ^a   Takei, Shin ^a   Hollingshead, Susan K ^b   Briles, David E ^b   Suzuki, Kenji ^c,d   Yamanaka, Noboru ^a,d  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c FUJITA HEALTH UNIVERSITY BANTANE HOSPITAL   (Japan)

^d Surveillance Subcommittee   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; PENICILLIN G; PNEUMOCOCCAL CAPSULAR TYPE AND SURFACE PROTEIN A; UNCLASSIFIED DRUG; VIRULENCE FACTOR;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM EXAMINATION; BACTERIUM ISOLATE; BROTH DILUTION; CHILD; FEMALE; GENE FREQUENCY; HUMAN; INFANT; JAPAN; MAJOR CLINICAL STUDY; MALE; MEFA GENE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRESCHOOL CHILD; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SCHOOL CHILD; SEROTYPE; SEX DIFFERENCE; STREPTOCOCCUS PNEUMONIAE; TAXONOMIC IDENTIFICATION; UPPER RESPIRATORY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; ANTI-INFECTIVE AGENTS; BACTERIAL PROTEINS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; JAPAN; MACROLIDES; MALE; MIDDLE AGED; PENICILLIN G; PNEUMOCOCCAL VACCINES; RESPIRATORY TRACT INFECTIONS; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; YOUNG ADULT;

EID: 84874593347     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058124     Document Type: Article

References (62)

1. Greenwood B, (1999) The epidemiology of pneumococcal infection in children in the developing world. Philos Trans R Soc Lond B Biol Sci 354: 777-785.
2. Hollingshead SK, Briles DE, (2001) Streptococcus pneumoniae: new tools for an old pathogen. Curr Opin Microbiol 4: 71-77.
3. Musher DM, Breiman RF, Tomasz A (2000) Streptococcus pneumoniae: at the threshold of the 21st century. In: Tomaz A editor. Streptococcus pneumoniae: Molecular biology and mechanisms of disease: Mary Ann Liebert, Inc., 485-491.
4. Yamanaka N, Hotomi M, Billal DS, (2008) Clinical bacteriology and immunology in acute otitis media in children. J Infect Chemother 14: 180-187.
5. Appelbaum PC, (1992) Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin Infect Dis 15: 77-83.
6. Breiman R, Butler JC, Tenover FC, Elliot J, Facklam RR, (1994) Emergence of drug-resistant pneumococcal infections in the United States. JAMA 271: 1831-1835.
7. Klugman KP, (1990) Pneumococcal resistance to antibiotics. Clin Microbiol Rev 3: 171-196.
8. Dagan R, Klugman KP, (2008) Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet Infect Dis 8: 785-795.
9. Whitney CG, Farley MM, Hadler J, Harrison LH, Lexau C, et al. (2000) Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med 343: 1917-1924.
10. Ortqvist A, Hedlund J, Burman LA, Elbel E, Höfer M, et al. (1998) Randomised trial of 23-valent pneumococcal capsular polysaccharide vaccine in prevention of pneumonia in middle-aged and elderly people. Swedish Pneumococcal Vaccination Study Group. Lancet 351: 399-403.
11. Cutts FT, Zaman SM, Enwere G, Jaffar S, Levine OS, et al. (2005) Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 365: 1139-1146.
12. Hsu HE, Shutt KA, Moore MR, Beall BW, Bennett NM, et al. (2009) Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N Engl J Med 360: 244-256.
13. Poehling KA, Talbot TR, Griffin MR, Craig AS, Whitney CG, et al. (2006) Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA 295: 1668-1674.
14. Whitney CG, Pilishvili T, Farley MM, Schaffner W, Craig AS, et al. (2006) Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 368: 1495-1502.
15. Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, et al. (2001) Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 344: 403-409.
16. Klugman KP, (2009) The significance of serotype replacement for pneumococcal disease and antibiotic resistance. Adv Exp Med Biol 634: 121-128.
17. Muñoz-Almagro C, Jordan I, Gene A, Latorre C, Garcia-Garcia J, et al. (2008) Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Clin Infect Dis 46: 174-182.
18. Razzaque R, Shah P, Watt JM, Mirza S, Coats MT, et al. (2012) Intranasal immunization of mice with neuraminidase A elicits virtually complete protection against nasopharyngeal colonization and subsequent invasion by Streptococcus pneumoniae. Infect Immun In submission.
19. Briles DE, Yother J, McDaniel LS, (1988) Role of pneumococcal surface protein A in the virulence of Streptococcus pneumoniae. Rev Infect Dis 10: S372-S374.
20. Ren B, Li J, Genschmer K, Hollingshead SK, Briles DE, (2012) The absence of PspA or presence of antibody to PspA facilitates the complement-dependent phagocytosis of pneumococci in vitro. Clin Vaccine Immunol 19: 1574-1582.
21. Ogunniyi AD, Lemessurier KS, Graham RM, Watt JM, Briles DE, et al. (2007) Contribution of pneumolysin, PspA, and PspC (CbpA) to pathogenicity of Streptococcus pneumoniae D39 in a mouse model. Infect Immun 75: 1843-1851.
22. Hollingshead SK, Becker RS, Briles DE, (2000) Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae. Infect Immun 68: 5889-5900.
23. Coral MCV, Fonseca N, Castaneda E, Di Fabio JL, Hollingshead SK, et al. (2001) Families of pneumococcal surface protein A (PspA) of Streptococcus pneumoniae invasive isolates recovered from Colombian children. Emerging Infectious Diseases 7: 832-836.
24. McDaniel LS, Sheffield JS, Swiatlo E, Yother J, Crain MJ, et al. (1992) Molecular localization of variable and conserved regions of pspA, and identification of additional pspA homologous sequences in Streptococcus pneumoniae. Microb Pathog 13: 261-269.
25. Roche H, Hakansson A, Hollingshead SK, Briles DE, (2003) Regions of PspA/EF3296 best able to elicit protection against Streptococcus pneumoniae in a murine infection model. Infect Immun. 71: 1033-1041.
26. Brooks-Walter A, McDaniel LS, Hollingshead SK, Crain MJ, Briles DE (1995) RFLP of the pspA gene from different isolates of Streptococcus pneumoniae reveal families of pspA. 35th ICAAC, San Franscisco, CA.: ASM Press.
27. Briles DE, Hollingshead SK, Nabors GS, Paton JC, Brooks-Walter A, (2000) The potential for using protein vaccines to protect against otitis media caused by Streptococcus pneumoniae. Vaccine 19: S87-S95.
28. Briles DE, Hollingshead SK, King J, Swift A, Braun PA, et al. (2000) Immunization of humans with rPspA elicits antibodies, which passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA. J Infect Dis 182: 1694-1701.
29. Briles DE, Ades E, Paton JC, Sampson JS, Carlone GM, et al. (2000) Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae. Infect Immun 68: 796-800.
30. Fukuyama Y, King JD, Kataoka K, Kobayashi R, Gilbert RS, et al. (2010) Secretory-IgA antibodies play an important role in the immunity to Streptococcus pneumoniae. J Immunol 185: 1755-1762.
31. Ferreira DM, Oliveira ML, Moreno AT, Ho PL, Briles DE, et al. (2010) Protection against nasal colonization with Streptococcus pneumoniae by parenteral immunization with a DNA vaccine encoding PspA (Pneumococcal surface protein A). Microb Pathog 48: 205-213.
32. Briles DE, Paton JC, Swiatlo E, Crain MJ (2006) Pneumococcal Vaccines. In: Fischetti VA, Novick RP, Ferretti JJ, Portnoy DA, Rood JI, editors. Gram Positive Pathogens. 2nd ed: ASM Press. 289-298.
33. Franco CM, Andrade AL, Andrade JG, Almeida e Silva S, Oliveira CR, et al. (2010) Survey of nonsusceptible nasopharyngeal Streptococcus pneumoniae isolates in children attending day-care centers in Brazil. Pediatr Infect Dis J 29: 77-79.
34. Shouval DS, Greenberg D, Givon-Lavi N, Porat N, Dagan R, (2009) Serotype coverage of invasive and mucosal pneumococcal disease in Israeli children younger than 3 years by various pneumococcal conjugate vaccines. Pediatr Infect Dis J 28: 277-282.
35. Chiba N, Morozumi M, Sunaoshi K, Takahashi S, Takano M, et al. (2010) Serotype and antibiotic resistance of isolates from patients with invasive pneumococcal disease in Japan. Epidemiol Infect 138: 61-68.
36. Weinstein MP, Klugman KP, Jones RN, (2009) Rationale for revised penicillin susceptibility breakpoints versus Streptococcus pneumoniae: coping with antimicrobial susceptibility in an era of resistance. Clin Infect Dis 48: 1596-1600.
37. Hollingshead SK, Baril L, Ferro S, King J, Coan P, et al. (2006) Pneumococcal surface protein A (PspA) family distribution among clinical isolates from adults over 50 years of age collected in seven countries. J Med Microbiol 55: 215-221.
38. Hollingshead SK, Becker R, Briles DE, (2000) Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae. Infect Immun 68: 5889-5900.
39. Briles DE, Tart RC, Swiatlo E, Dillard JP, Smith P, et al. (1998) Pneumococcal diversity: considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA). Clin Microbiol Rev 11: 645-657.
40. Jedrzejas MJ, Hollingshead SK, Lebowitz J, Chantalet L, Briles DE, et al. (2000) Production and characterization of the functional fragment of pneumococcal surface protein A. Arch Biochem Biophys. 373: 116-125.
41. Jedrzejas MJ, Lamani E, Becker RS, (2001) Characterization of selected strains of pneumococcal surface protein A. J Biol Chemi. 276: 33121-33128.
42. Nabors GS, Braun PA, Herrmann DJ, Heise ML, Pyle DJ, et al. (2000) Immunization of healthy adults with a single recombinant pneumococcal surface protein A (PspA) variant stimulates broadly cross-reactive antibodies to heterologous PspA molecules. Vaccine 18: 1743-1754.
43. Vala Coral MC, Fonseca N, Castaneda E, Di Fabio JL, Hollingshead SK, et al. (2001) Pneumococcal surface protein A of invasive Streptococcus pneumoniae isolates form Colombian children. Emerg Infect Dis 7: 832-836.
44. Tart RC, McDaniel LS, Ralph BA, Briles DE, (1996) Truncated Streptococcus pneumoniae PspA molecules elicit cross-protective immunity against pneumococcal challenge in mice. J Infect Dis 173: 380-386.
45. Briles DE, Hollingshead SK, King J, Swift A, Braun PA, et al. (2000) Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA. J Infect Dis 182: 1694-1701.
46. Darrieux M, Miyaji EN, Ferreira DM, Lopes LM, Lopes AP, et al. (2007) Fusion proteins containing family 1 and family 2 PspA fragments elicit protection against Streptococcus pneumoniae that correlates with antibody-mediated enhancement of complement deposition. Infect Immun 75: 5930-5938.
47. Mollerach M, Regueira M, Bonofiglio L, Callejo R, Pace L, et al. (2004) Streptococcus pneumoniae Working Group: Invasive Streptococcus pneumoniae isolates from Argentinean children: serotypes, families of pneumococcal surface protein A (PspA) and genetic diversity. Epidemiol Infect 132: 177-184.
48. Brandileone MC, Andrade AL, Teles EM, Zanella RC, Yara TI, et al. (2004) Typing of pneumococcal surface protein A (PspA) in Streptococcus pneumoniae isolated during epidemiological surveillance in Brazil: towards novel pneumococcal protein vaccines. Vaccine 28: 3890-3896.
49. Pimenta FC, Ribeiro-Dias F, Brandileone MCC, Miyaji EN, Leite LCC, et al. (2006) Genetic diversity of PspA types among nasopharyngeal isolates collecting during an ongoing surveillance study of children in Brazil. J Clin Microbiol 44: 2838-2843.
50. Beall B, Gherardi G, Fracklam RR, Hollingshead SK, (2000) Pneumococcal pspA sequence types of prevalent multiresistant pneumococcal strains in the United States and of internationally disseminated clones. J Clin Microbiol 38: 3663-3669.
51. Heeg C, Franken C, van der Linden M, Ai-Lahlam A, Reiner RR, (2007) Genetic diversity of pneumococcal surface protein A of Streptococcus pneumoniae meningitis in German children. Vaccine 25: 1030-1035.
52. Rolo D, Ardanuy C, Fleites A, Martín R, Liñares J, (2009) Diversity of pneumococcal surface protein A (PspA) among prevalent clones in Spain. BMC Microbiol 9: 80-86.
53. Sadowy E, Skoczynska A, Fiett J, Gniadkowski M, Hryniewicz W, (2006) Multilocus sequence types, serotypes, and variants of the surface antigen PspA in Streptococcus pneumoniae isolates from meningitis patients in Poland. Clin Vaccine Immunol 13: 139-144.
54. Melin MM, Hollingshead SK, Briles DE, Hanage WP, Lahdenkari M, et al. (2008) Distribution of pneumococcal surface protein A families 1 and 2 among Streptococcus pneumoniae isolates from children in finland who had acute otitis media or were nasopharyngeal carriers. Clin Vaccine Immunol 15: 1555-1563.
55. Imai S, Ito Y, Ishida T, Hirai T, Ito I, et al. (2011) Distribution and clonal relationship of cell surface virulence genes among Streptococcus pneumoniae isolates in Japan. Clin Microbiol Infect 17: 1409-1414.
56. Ito Y, Osawa M, Isozumi R, Imai S, Ito I, et al. (2007) Pneumococcal surface protein A family types of Streptococcus pneumoniae from community-acquired pneumonia patients in Japan. Eur J Clin Microbiol Infect Dis 26: 739-742.
57. Crain MJ, Turner JS, Robinson DA, Coffey TJ, Brooks-Walter A, et al. (1996) Evidence for the simultaneous expression of two PspAs by a clone of capsular serotype 6B Streptococcus pneumoniae. Microb Pathog 21: 265-275.
58. Robinson DA, Turner JS, Facklam RR, Parkinson AJ, Breiman RF, et al. (1999) Molecular characterization of a globally distributed lineage of serotype 12F Streptococcus pneumoniae causing invasive disease. J Infect Dis 179: 414-422.
59. Niki Y, Hanaki H, Matsumoto T, Yagisawa M, Kohno S, et al. (2009) Nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy in 2007: general view of the pathogens' antibacterial susceptibility. J Infect Chemother 15: 156-167.
60. Niki Y, Hanaki H, Yagisawa M, Kohno S, Aoki N, et al. (2008) The first nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy. Part 1: a general view of antibacterial susceptibility. J Infect Chemother 14: 279-290.
61. Hotomi M, Billal DS, Shimada J, Suzumoto M, Yamauchi K, et al. (2006) High prevalence of Streptococcus pneumoniae with mutations in pbp1a, pbp2x, and pbp2b genes of penicillin-binding proteins in the nasopharynx in children in Japan. ORL J Otorhinolaryngol Relat Spec 68: 139-145.
62. Hotomi M, Billal DS, Kamide Y, Kanesada K, Uno Y, et al. (2008) Serotype distribution and penicillin resistance of Streptococcus pneumoniae isolates from middle ear fluids of pediatric patients with acute otitis media in Japan. J Clin Microbiol 46: 3808-3810.